Global Life Sciences Market Overview
Life science is a massive field of study which examines every living thing on earth. Life science studies life in all its forms, past and present. This can include plants, animals, viruses and bacteria, single-celled organisms, and even cells. Life sciences study the biology of how these organisms live. Life science and healthcare industry has been generating huge amount of data related to scientific research, patient profiles, compliance and regulatory requirements over the period. The global life sciences market is expected to reach $1.7 trillion by 2023.
Impact of COVID-19 on the market
The outbreak of COVID-19 has raised the demand for a number of kits and rapid tests. As screening is being performed at a massive scale during this outbreak hotspot. There is a huge demand for Covid-19 screening as a crucial factor for revenue growth in this market space. Additionally, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who might need critical care. Besides, there is an urgent requirement for a rapid acceleration in the manufacturing process for an extensive range of test-kits. This report will quantify the impact of this pandemic on the life sciences market.
Global Life Sciences Market Dynamics
The life sciences sector is at a modulation point. The promise of cell and gene therapies is being delivered to patients. Artificial intelligence (AI) and machine learning approaches are raising expectations that therapy discovery and development may not only be more innovative but also more time- and cost-effective.
Data-driven approaches have the potential to create value across manufacturing, the supply chain, and the entire health care ecosystem. As technology and behavioural science converge, the focus is increasingly shifting to disease prevention.
Consumer wearables now have medical-grade sensors, and telemedicine, remote monitoring, and virtual trials are reducing complexity for patients. Medical algorithms and connected devices are delivering data everywhere.
In 2020, biopharma organizations are looking for new ways to create value and new metrics to make sense of all the data. As patient-centric models have been adopted within the industry, they are now informing operational approaches and setting the foundation of personalized health care. The human experiences of patients, the workforce, and ecosystem partners are interrelated and affect business outcomes. With the goal of creating value for all stakeholders, organizations can aspire to find real value for themselves and their shareholders in the coming year.
Conversely, high implementation cost and lack of skilled professionals are the major factors restraining the growth of the global life sciences market.
Global Life Sciences Market Segmentation
The global life sciences market is segmented based on the types, application, end-user, and region.
On the basis of the types, the global life sciences market is segmented into ecology, botany, zoology, entomology, microbiology, cell biology, physiology, genetics, and others. Based on the application, the target market is segmented into drug discovery and development, basic research, toxicity screening, biopharmaceutical production, drug screening, tissue engineering, and forensic testing. Based on the end-user, the target market is classified into biopharmaceutical companies, contract research organizations (CROs), academic & research institutes, forensic science laboratories, food & beverage companies, diagnostic centres, and others.
In the region, the global life sciences market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia pacific life science market is experiencing significant growth from the past few years. There has been a shift in investments in technology and R &D activities, particularly in the life sciences sector, from North America and Europe to the Asia Pacific. Emerging economies such as India have plenty of skilled labour and capable manpower at affordable costs thereby growing the scope for attracting outsourcing of biotech projects. Moreover, numerous governments in the Asia Pacific region have started taking initiatives to support the growth of the domestic biotechnology industry by providing tax exemptions on R&D initiatives, creating public and private conglomerates, growing budgets and funding, and attracting foreign direct investments
|
Attribute |
Details |
|
The base year for estimation |
2020 |
|
Forecast period |
2020 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Types - Ecology, Botany, Zoology, Entomology, Microbiology, Cell Biology, Physiology, Genetics, and Others By Application - Drug Discovery and Development, Basic Research, Toxicity Screening, Biopharmaceutical Production, Drug Screening, Tissue Engineering, and Forensic Testing By End-user - On-premise LIMS, Cloud-based LIMS, and Remotely Hosted LIMS |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2029. For the purpose of this study, has segmented the global life sciences market report based on types, application, end-user, and region.
Global Life sciences market, By Types:
- Ecology
- Botany
- Zoology
- Entomology
- Microbiology
- Cell Biology
- Physiology
- Genetics
- Others
Global Life sciences market, By Application:
- Drug Discovery and Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
Global Life sciences market, By End-user:
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Food & Beverage Companies
- Diagnostic Centers
- Others
Global Life sciences market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Life Sciences Market Key Players
The key players operating in the global life sciences market include Abcam Plc, A.M.S. Biotechnology (Europe) Limited, Crown Bioscience Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., Merck Millipore Limited, Genscript Biotech Corporation, BPS Bioscience Inc., Sigma Aldrich Corp., and Thermo Fisher Scientific Inc. Key players are focusing on adopting strategies such as new product launches, partnership, regional expansion, and distribution agreements to expand their revenue share. Thermo Fisher Scientific is one of the biggest suppliers of an extensive innovative solutions for the life science community worldwide. The company’s portfolio includes nucleic acid purification solutions, sequencing solutions, flow cytometry instruments, thermal cyclers, and other laboratory supplies. The company’s products are utilized by healthcare professionals and researchers across the globe.
Global Life Sciences Market Key Issues Addressed
Key Issues Addressed
Global Life Sciences Market Company Profile
- Abcam Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- A.M.S. Biotechnology (Europe) Limited
- Crown Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- Merck Millipore Limited
- Genscript Biotech Corporation
- BPS Bioscience, Inc.
- Sigma Aldrich Corp.
- Thermo Fisher Scientific Inc.
“*” marked represents similar segmentation in other categories in the respective section
Global Life Sciences Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Application Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Life Sciences Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Life Sciences Market, By Type, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Ecology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Botany
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Zoology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Entomology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Microbiology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Cell Biology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Physiology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Genetics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Life Sciences Market, By Application, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Drug Discovery and Development
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Basic Research
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Toxicity Screening
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Biopharmaceutical Production
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Drug Screening
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Tissue Engineering
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Forensic Testing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Life Sciences Market, By End-user, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Biopharmaceutical Companies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Contract Research Organizations (CROs)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Academic & Research Institutes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Forensic Science Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Food & Beverage Companies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Diagnostic Centers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Life Sciences Market, By Region, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Abcam Plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- A.M.S. Biotechnology (Europe) Limited
- Crown Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- Merck Millipore Limited
- Genscript Biotech Corporation
- BPS Bioscience, Inc.
- Sigma Aldrich Corp.
- Thermo Fisher Scientific Inc.
- Abcam Plc
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global life sciences market is segmented based on types, application, end-user, and region.
Growth in investments by government and non-government organizations for R&D linked life sciences research and academics are projected to boost the target market growth.
Asia pacific life science market is experiencing significant growth from the past few years.
Key players are focusing on adopting strategies such as new product launches, partnership, regional expansion, and distribution agreements to expand their revenue share.